Aramark (ARMK): what the price requires

At today's price, Aramark (ARMK) is priced for +23.4% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/ARMK

Headline

FieldValue
TickerARMK
CompanyAramark
Current price$58.15/sh
CompositionBusiness & Industry 10% / Education 21% / Healthcare 9% / Sports, Leisure & Corrections 23% / Facilities & Other 9% / Europe 16% / Rest of World 13%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed2.7%
Operating margin today4.3%
Margin compression implied-1.6pp
Implied growth23.4%
Multiple paid27x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 9% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.9pp.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.59σ
cohort percentile (of 212 peers)76
sustained it ~5 years at this level33%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.69x4expensive
Earnings4.01x3expensive
Relative1.16x5expensive
Growth1.01x1expensive

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.6%); the inversion above states its own rate.

Per-Model Detail (n=13)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$50.071.16xyesP/E 32.62x (blended: static sector reference 28x + trailing (TTM) 43x), scenarios: 27.0x / 32.6x / 38.2x (bear / base = reference held flat / bull), EV/EBITDA 18x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$14.494.01xyesBV/sh $12.31, ROE (TTM) 10.9%, ke 9.3%
Two-Stage Excess ReturnAsset$15.673.71xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$57.851.01xyesRev $19.4B, growth 10% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.8x / 0.9x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$17.423.34xyesEPS $1.34, growth 13% (input: historical EPS growth), PEG=3.34 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$5.1811.23xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.73B × (1−26%) / WACC 7.6% → EPV (no growth)
Residual IncomeAsset$15.893.66xyesBV $12.31 + 5yr PV of (ROE (TTM) 10.9% − Kₑ 9.3%) × BV; BV grows 7.1%/yr
Graham NumberAsset$19.273.02xyes√(22.5 × EPS $1.34 × BVPS $12.31) — Graham's conservative floor
EV/EBITDA RelativeRelative$51.851.12xyesEBITDA $1.10B × sector EV/EBITDA 18.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$38.741.50xyesEPS $1.34 × (8.5 + 2×13.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$2.8620.33xyesBV $12.31 × (ROIC 1.8% / WACC 7.6%) (excluded from median)
P/Sales SectorRelative$327.950.18xyesRevenue $19.41B × sector P/S 4.5x
PEG Fair ValueRelative$26.132.23xyesEPS $1.34 × (PEG 1.5 × growth 13.0% (input: historical EPS growth)) → PE 19.5x
Earnings YieldEarnings$14.494.01xyesEPS $1.34 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$5.6b
Net debt / NOPAT (after-tax)9.52x
Net debt / operating income (pre-tax)7.07x
Share count CAGR (buyback)-7.1%
Burning cashyes

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Start with the obvious objection, because the bull case has to answer it. Aramark earns an operating margin of only about 4%, the kind of razor-thin profitability that makes a business look fragile and leaves little room for error. But thin margins are how contract food and facilities services has always worked, and the question that matters is not the level of the margin, it is the direction and the volume underneath it. On that test the recent data is strong. Organic revenue grew 12% in fiscal Q2 2026 to $4.8 billion, and adjusted operating income margin expanded 50 basis points in the quarter. A low margin that is widening on a growing revenue base compounds into real operating-profit growth, which is exactly what the price is paying for.

The growth is coming from winning new contracts, the cleanest signal in this business. New client wins reached $1 billion year-to-date, an unprecedented pace, and net new business contributed about 5% of organic growth in the quarter. The company competes in a market it describes as having "significant competition in the food and support services business from local, regional, national and international companies", so taking share at this rate against well-resourced rivals is evidence of a real commercial advantage, not just a rising tide.

The single most striking development is the move into data-center services. The company's initial contract with a hyperscaler is set to become the largest in Aramark's history, with annualized revenue potential of several hundred million dollars, and it is not yet reflected in current guidance. That matters twice over: it opens a large new vertical riding the same AI-infrastructure buildout powering the rest of the market, and it is upside the published outlook does not yet count. Management raised fiscal 2026 organic revenue guidance to the high end of its 7% to 9% range and reaffirmed adjusted earnings-per-share growth of 20% to 25%. The bull case is that a defensive, recurring services business is quietly turning into a share-gaining growth story with margin leverage and a new vertical the price has not yet paid for.

Bear Case

The price is leaning on a specific chain of assumptions, and the most fragile link is margin expansion compounding for years. At about $53 (June 27, 2026) the units trade near 25 times operating income, which inverts to roughly 21% annual operating-profit growth sustained for five years. That is a demanding bar for a business whose operating margin is only about 4%, because the math depends on both revenue growing and the margin widening at the same time, repeatedly. A single bad cost cycle breaks it. Food and labor inflation, the two largest costs in this business, are exactly the variables Aramark does not control, and many of its contracts pass cost through only with a lag. If wages or food costs run ahead of the repricing, the margin expansion the price assumes reverses into compression.

The second fragile assumption is that the leverage stays benign. Net debt of about $5.6 billion is roughly seven times operating income, and the company's own filing warns that its indebtedness risks "placing us at a competitive disadvantage compared to our competitors who are less highly leveraged". The structural cost of that debt shows up in returns: the return on the total capital invested in the business is barely above 1%, a sign that the goodwill and debt from past acquisitions are not yet earning their keep. The filing is also explicit that breaching its leverage covenant could "result in the requirement to immediately repay all amounts outstanding under the Credit Agreement". A highly levered, thin-margin business has a narrow path: it must grow into the debt, and a stumble in margin or a rise in rates widens the gap rather than closing it.

The third dependency is the new-vertical narrative itself. The hyperscaler data-center contract is genuinely promising, but it is one contract, not yet in guidance, and the bull case increasingly leans on it to justify a premium multiple. Concentrating the growth story on a single marquee win introduces exactly the customer-concentration risk a contract services business is supposed to diversify away. If that contract underdelivers, ramps slower than hoped, or the broader new-business pipeline cools from its current record pace, the price has paid for a growth rate the demonstrated economics, low margins, low returns on capital, and heavy debt, do not comfortably support.

Valuation

What the price is betting is straightforward and demanding. At about $53 a share, Aramark trades near 25 times company-wide operating income, which inverts to roughly 21% annual operating-profit growth sustained for about five years. Keep the figure approximate; it is one solve under fixed assumptions. The nuance the inversion flags is that the rate is within what Aramark has recently delivered, so the stretch is in how long that pace must persist, not in whether it is achievable for a year. Historically only about a third of comparable fast-growers sustained that pace for five years.

The methods split along the line that separates a growth bet from a value one. The relative-multiple family is what justifies the price: a sector price-to-earnings near 28 times and a sector EV-to-EBITDA comparison both land in the high $40s to low $50s, right around the current price. The asset and earnings-power families land far below, in the mid-teens, because the business carries a low return on equity and heavy goodwill from past deals. Read together, the price is supported by what peers in the broader services and consumer space trade at, not by what the company's own assets or current earnings power would independently support. That makes the multiple a relative-value judgment that holds only as long as the growth and margin trajectory keeps pace.

Solvency is the part of the picture the buyer must weigh most carefully, because this is a levered company. Net debt of about $5.6 billion sits at roughly seven times operating income, which means a meaningful slice of operating profit is committed to interest before any reaches equity holders. The decisive question the valuation poses is whether the accelerating organic growth and widening margin can compound fast enough, for long enough, to both service the debt and grow into a 25-times multiple. The data-center contract and the record new-business pace are the upside the price has not fully counted; the leverage and the thin margin are why the downside, if growth stalls, is amplified.

Catalysts

Fiscal second-quarter 2026 results, reported in May, showed the growth accelerating. Organic revenue grew 12% to $4.8 billion, including an estimated 3% benefit from a calendar shift, and adjusted operating income margin expanded 50 basis points. Base growth split into about 3% pricing and 1% volume, with net new business adding roughly 5%. These are company-defined organic and adjusted measures; the GAAP earnings base remains thinner.

The forward catalysts are the raised outlook and one marquee contract. Management lifted fiscal 2026 organic revenue guidance to the high end of its 7% to 9% range, reaffirmed adjusted operating income growth of 12% to 17%, and reaffirmed adjusted earnings-per-share growth of 20% to 25%. New client wins reached $1 billion year-to-date. The standout is the hyperscaler data-center contract, set to become the largest in the company's history with annualized revenue potential of several hundred million dollars and explicitly not yet in 2026 guidance. The next several quarters will test whether that contract ramps as framed and whether the margin expansion holds against food and labor costs; both feed directly into the growth rate the price requires.

Peer Cohorts (Per Segment, With Filing Citations)

FSS United States (reported)

FSS International (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q2 FY2026 earnings, May 12 2026 · FY2025 10-K

View the full interactive ARMK report on boothcheck